{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:23Z","timestamp":1787440943102,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031734","name":"Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda","doi-asserted-by":"publisher","award":["49\/2015"],"award-info":[{"award-number":["49\/2015"]}],"id":[{"id":"10.13039\/100031734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/02557"],"award-info":[{"award-number":["PI12\/02557"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/00041"],"award-info":[{"award-number":["PI13\/00041"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["MITIC\\u2011CM\\u20112022"],"award-info":[{"award-number":["MITIC\\u2011CM\\u20112022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022924","name":"Spanish Working Group on Crohn's Disease and Ulcerative Colitis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119508","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:19:52Z","timestamp":1780039192000},"page":"119508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Th1\/Th17 cytokine signatures correlate with Crohn\u2019s disease activity in a 54\u2011week cohort of patients treated with adalimumab"],"prefix":"10.1016","volume":"200","author":[{"given":"Patricia","family":"de Castro-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis G.","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Monserrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-2515","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Iborra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Cabriada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bujanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valle","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mar\u00edn-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Mart\u00edn-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mesonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-3529","authenticated-orcid":false,"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Hinojosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"G\u00f3mez-Lahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-7855","authenticated-orcid":false,"given":"Cielo","family":"Garc\u00eda-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Fraile-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego L.","family":"Boaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"\u00c1lvarez-Mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119508_bib1","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119508_bib2","first-page":"1177","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024"},{"key":"10.1016\/j.biopha.2026.119508_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 2: IBD scores and general principles and technical aspects","volume":"13","author":"Sturm","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2026.119508_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae082","article-title":"Epidemiology of inflammatory bowel disease across the ages in the era of advanced therapies","volume":"18","author":"Caron","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2026.119508_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohns Colitis"},{"issue":"22","key":"10.1016\/j.biopha.2026.119508_bib6","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.3390\/jcm10225318","article-title":"Primary failure to an Anti-TNF agent in inflammatory bowel disease: switch (to a Second Anti-TNF Agent) or swap (for Another Mechanism of Action)","volume":"10","author":"Gisbert","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2026.119508_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2026.119508_bib8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2026.119508_bib9","doi-asserted-by":"crossref","unstructured":"Feagan B.G., Sandborn W.J., Gasink C., Jacobstein D., Lang Y., Friedman J.R., et al. Ustekinumab as Induction and Maintenance Therapy for Crohn\u2019s Disease. N Engl J Med;375:1946\u20131960. https:\/\/doi.org\/10.1056\/NEJMOA1602773.","DOI":"10.1056\/NEJMoa1602773"},{"key":"10.1016\/j.biopha.2026.119508_bib10","first-page":"2015","article-title":"Risankizumab as induction therapy for Crohn\u2019s disease: results from the phase 3 ADVANCE and MOTIVATE induction trials","volume":"399","author":"D\u2019Haens","year":"2022"},{"key":"10.1016\/j.biopha.2026.119508_bib11","first-page":"2031","article-title":"Risankizumab as maintenance therapy for moderately to severely active Crohn\u2019s disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","volume":"399","author":"Ferrante","year":"2022"},{"key":"10.1016\/j.biopha.2026.119508_bib12","first-page":"144","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019"},{"key":"10.1016\/j.biopha.2026.119508_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-023-00863-y","article-title":"Mild Crohn\u2019s disease: definition and management","volume":"25","author":"Claytor","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.biopha.2026.119508_bib14","first-page":"480","article-title":"Evidence-based approach to the management of Mild Crohn\u2019s disease","volume":"22","author":"Elmasry","year":"2024"},{"key":"10.1016\/j.biopha.2026.119508_bib15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41590-021-01009-w","article-title":"Repositioning TH cell polarization from single cytokines to complex help","volume":"22","author":"Tuzlak","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2026.119508_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119508_bib17","first-page":"992","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immun. Cell Press"},{"key":"10.1016\/j.biopha.2026.119508_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jcag\/gwad024","article-title":"Biomarkers that predict Crohn\u2019s disease outcomes","volume":"7","author":"Olivera","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119508_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/00365521.2017.1339825","article-title":"Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn\u2019s disease","volume":"52","author":"Billiet","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119508_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000511641","article-title":"Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches","volume":"39","author":"Dragoni","year":"2021","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2026.119508_bib21","first-page":"790","article-title":"Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease","volume":"3","author":"Atreya","year":"2018"},{"key":"10.1016\/j.biopha.2026.119508_bib22","first-page":"24","article-title":"Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity","author":"Menesy","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119508_bib23","first-page":"10","article-title":"Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update","author":"Lotfi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119508_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: a promising target in inflammation and autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.biopha.2026.119508_bib25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2026.119508_bib26","first-page":"16","article-title":"IL-7 in autoimmune diseases: mechanisms and therapeutic potential","author":"Zeng","year":"2025","journal-title":"Front Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:50:42Z","timestamp":1787439042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S0753332226005445"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119508","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Th1\/Th17 cytokine signatures correlate with Crohn\u2019s disease activity in a 54\u2011week cohort of patients treated with adalimumab","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119508"}}